Stockreport

ALX Oncology Announces Pricing of Underwritten Offering

ALX Oncology Holdings Inc.  (ALXO) 
PDF SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advanc [Read more]